Showing results (11-20 of 1,609) with videos related to
Sort By:
Pageof 161
Zhonghua Yi Xue Za Zhi|February 26, 2005
[Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]Xin-hua Xiao, Hou-de Zhou, Ling-qing Yuan, et al.Zhonghua Yi Xue Za Zhi|October 30, 2008
[Adiponectin regulates the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in human osteoblast]Xiang-Mei Zhang, Hui Xie, Ling-Qing Yuan, et al.Molecular Medicine Reports|April 12, 2011
Is it necessary to control the level of estrogen receptor α and β activation in postmenopausal hormone replacement therapy in order to achieve the optimal outcome? (Review)Bao Ting ZhuInternational Journal of Molecular Medicine|February 10, 2004
CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's diseaseBao Ting ZhuJournal of Molecular Cell Biology|November 19, 2025
Pathogenic Mechanism Underlying Parkinsonism Induced by Neurotoxicants (MPTP and 6-Hydroxydopamine) and α-Synuclein: A Unifying HypothesisBao Ting ZhuMolecules (Basel, Switzerland)|July 28, 2026
Cholesterol at the Center of Alzheimer's Disease: A Unifying Hypothesis on the Pathogenic MechanismBao Ting ZhuCurrent Drug Metabolism|June 27, 2002
Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesisBao Ting ZhuBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 30, 2005
Mechanistic explanation for the unique pharmacologic properties of receptor partial agonistsBao Ting ZhuExpert Opinion on Drug Metabolism & Toxicology|February 2, 2010
On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerationsBao Ting ZhuPageof 161